advertisement
 

  Back to Research News Research News and Information

BIOCONTROL TECHNOLOGY, INC.
2275 Swallow Hill Road - Building 2500 - Pittsburgh, PA 15220
(412) 429-0673 Fax: (412) 279-1367

Press Release


BIOCONTROL HAS MEETING WITH FDA

Pittsburgh, PA - November 14, 1996 - Biocontrol Technology, Inc. (NASDAQ:BICO) announced today that its top executives and scientists met with the Food and Drug Administration (FDA) late Wednesday afternoon, November 13, 1996, regarding the Company's recently submitted 510(k) for the Diasensor 1000TM noninvasive glucose sensor for diabetics.

At the meeting, discussion centered around the FDA's request for an in-home study to finalize the approval process.

Biocontrol will therefore respond to the FDA as soon as possible with a proposed in-home study plan.

The Company further announced that its 510(k) has been withdrawn by the FDA since it will need to be amended with the in-home study data.

Biocontrol Technology, Inc. has its corporate offices in Pittsburgh, PA and is involved in the development and manufacture of biomedical devices and environmental products.

###



                 
  Home Return to Top

Last Updated: Thursday February 27, 2014 19:28:21
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents.
By using this site, you agree to our Terms of Use, Legal Notice, and Privacy Policy.
© Children with Diabetes, Inc. 1995-2015. Comments and Feedback.